Literature DB >> 18836844

Calcium and the saga of the binders: accumulating controversy, or building consensus?

David J A Goldsmith1, Adrian Covic.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18836844     DOI： 10.1007/s11255-008-9477-x

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN： 0301-1623            Impact factor:   2.370


× No keyword cloud information.
  22 in total

1.  Calcification in CKD: no closer to the cure.

Authors:  Bryan Kestenbaum
Journal:  Am J Kidney Dis       Date:  2008-06       Impact factor: 8.860

Review 2.  Vascular calcification: pathobiology of a multifaceted disease.

Authors:  Linda L Demer; Yin Tintut
Journal:  Circulation       Date:  2008-06-03       Impact factor: 29.690

3.  Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO).

Authors:  S Moe; T Drüeke; J Cunningham; W Goodman; K Martin; K Olgaard; S Ott; S Sprague; N Lameire; G Eknoyan
Journal:  Kidney Int       Date:  2006-06       Impact factor: 10.612

4.  The natural history of coronary calcification progression in a cohort of nocturnal haemodialysis patients.

Authors:  Darren Yuen; Andreas Pierratos; Robert M A Richardson; Christopher T Chan
Journal:  Nephrol Dial Transplant       Date:  2006-02-27       Impact factor: 5.992

5.  Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.

Authors:  Geoffrey A Block; David M Spiegel; James Ehrlich; Ravindra Mehta; Jill Lindbergh; Albert Dreisbach; Paolo Raggi
Journal:  Kidney Int       Date:  2005-10       Impact factor: 10.612

6.  Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis.

Authors:  Christoph Wanner; Vera Krane; Winfried März; Manfred Olschewski; Johannes F E Mann; Günther Ruf; Eberhard Ritz
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

7.  The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer.

Authors:  D Russo; I Miranda; C Ruocco; Y Battaglia; E Buonanno; S Manzi; L Russo; A Scafarto; V E Andreucci
Journal:  Kidney Int       Date:  2007-09-05       Impact factor: 10.612

8.  A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: the Calcium Acetate Renagel Evaluation-2 (CARE-2) study.

Authors:  Wajeh Qunibi; Moustafa Moustafa; Larry R Muenz; David Y He; Paul D Kessler; Jose A Diaz-Buxo; Mathew Budoff
Journal:  Am J Kidney Dis       Date:  2008-04-18       Impact factor: 8.860

Review 9.  Bone and mineral disorders in pre-dialysis CKD.

Authors:  Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

10.  Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients.

Authors:  J Braun; M Oldendorf; W Moshage; R Heidler; E Zeitler; F C Luft
Journal:  Am J Kidney Dis       Date:  1996-03       Impact factor: 8.860
View more
  2 in total

1.  Short-term efficacy of sevelamer versus calcium acetate in patients with chronic kidney disease stage 3-4.

Authors:  Ashima Gulati; Vijesh Sridhar; Tathagata Bose; Pankaj Hari; Arvind Bagga
Journal:  Int Urol Nephrol       Date:  2009-12-18       Impact factor: 2.370

2.  Clinical usefulness of lanthanum carbonate for serum phosphate control in difficult patients.

Authors:  J Almirall; L Betancourt; V Esteve; M P Valenzuela; T López; A Ruiz; J C Martínez-Ocaña; X Calvet
Journal:  Int Urol Nephrol       Date:  2010-11-11       Impact factor: 2.370
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.